These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1515567)

  • 1. Effects of a gastric mucosal protecting agent in rats with liver cirrhosis.
    Kurihara T; Akimoto M; Kurokawa K; Ishiguro H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Yokoyama I
    J Gastroenterol Hepatol; 1992; 7(4):405-10. PubMed ID: 1515567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in hepatic tissue blood flow by teprenone.
    Kurihara T; Kitamura Y; Adachi Y; Obuchi M; Abe K; Akimoto M; Hashimoto H; Ishiguro H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Yokoyama I
    J Gastroenterol Hepatol; 1996 Oct; 11(10):978-84. PubMed ID: 8912138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
    Morimoto Y; Shimohara K; Oshima S; Sukamoto T
    Jpn J Pharmacol; 1991 Dec; 57(4):495-505. PubMed ID: 1803065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protection of gastric mucosa against steroids-induced damage by teprenone].
    Lü B; Zhang L; Fan YH; Meng LN; Zhang S
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2749-53. PubMed ID: 16324314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
    Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
    Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone.
    Sugimoto M; Machida Y; Ito K
    J Gastroenterol Hepatol; 1999 Jun; 14(6):529-33. PubMed ID: 10385060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of teprenone on portal hypertensive gastric mucosa.
    Tanoue K; Tarnawski AS; Kishihara F; Ohta M; Hashizume M; Sugimachi K; Sarfeh IJ
    Digestion; 1996; 57(1):35-40. PubMed ID: 8626046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of teprenone on acute gastric mucosal lesions induced by cold-restraint stress.
    Kunisaki C; Sugiyama M
    Digestion; 1992; 53(1-2):45-53. PubMed ID: 1289172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
    J Pharmacol Sci; 2003 Nov; 93(3):337-46. PubMed ID: 14646252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive effect of teprenone on acute gastric mucosal lesion progression in compound 48/80-treated rats.
    Ohta Y; Kobayashi T; Inui K; Yoshino J; Kitagawa A; Nakazawa S
    Eur J Pharmacol; 2004 Mar; 487(1-3):223-32. PubMed ID: 15033395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teprenone promotes the healing of acetic acid-induced chronic gastric ulcers in rats by inhibiting neutrophil infiltration and lipid peroxidation in ulcerated gastric tissues.
    Kobayashi T; Ohta Y; Yoshino J; Nakazawa S
    Pharmacol Res; 2001 Jan; 43(1):23-30. PubMed ID: 11207062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of teprenone on blood flow and incidence of histologic lesions in rat gastric mucosa after hemorrhage and retransfusion.
    Hachiya A; Bessho M; Iwasaki T; Iida K; Otsuka S
    Scand J Gastroenterol; 1996 Apr; 31(4):326-33. PubMed ID: 8726298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and preventive effects of teprenone on gastric mucosal lesions in rats.
    Nishida K; Ohta Y; Ishiguro I
    Eur J Pharmacol; 1998 Jul; 354(1):51-8. PubMed ID: 9726630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Teprenone in the treatment of chronic superficial gastritis, a multicentre study].
    Liu X; Jia B; Lin S
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):12-4. PubMed ID: 9275638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of teprenone on expression of heat shock protein 70 and c-fos in stomach following prednisolone ingestion: experiment with rats].
    Lü B; Zhang L; Fan YH; Xu Y
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):220-4. PubMed ID: 18361829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric mucosal hexosamine content in various liver diseases.
    Sakai M; Sagara K; Fujiyama S; Murata H; Sato T
    Hepatogastroenterology; 1991 Aug; 38(4):302-6. PubMed ID: 1657747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive effects of teprenone on gastric mucosal lesions induced by Helicobacter pylori in mice].
    Yang GB; Hu FL; Mu FH
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):992-5. PubMed ID: 16759543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of teprenone on stress-induced gastric mucosal lesions and its relation to gastric mucosal constitutive nitric oxide synthase activity.
    Nishida K; Ohta Y; Ishiguro I
    Pharmacol Res; 1999 Apr; 39(4):325-32. PubMed ID: 10208764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
    Onoda Y; Takido M; Magaribuchi T; Tamaki H
    Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesions in D-galactosamine-induced hepatitis rats.
    Taniguchi H; Yomota E; Nogi K; Onoda Y
    Arzneimittelforschung; 2002; 52(8):600-4. PubMed ID: 12236047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.